Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study

PURPOSE: In contrast to the Western diffuse large B-cell lymphoma (DLBCL), prognostic impact of age in a Korean population with DLBCL has not been fully evaluated. MATERIALS AND METHODS: Six hundred and eight DLBCL patients treated with rituximab-containing chemotherapeutic regimens from January 200...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res Treat
Main Authors: Hwang, Hee Sang, Kim, Meejeong, Park, Chan-Sik, Yoon, Dok Hyun, Suh, Cheolwon, Huh, Jooryung, Go, Heounjeong
Format: Artigo
Jezik:Inglês
Izdano: Korean Cancer Association 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812004/
https://ncbi.nlm.nih.gov/pubmed/32972046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2020.626
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki